The International Forum of Pharmaceutical Regulators (IPRF) and the International Program for the Regulation of Generic Drugs (IGDRP) have agreed to consolidate their work in a joint initiative to be operational in January 2018.
According to a summary of the 5th IGDRP meeting in Ottawa in June, the IPRF Management Committee and the IGPRR Steering Committee expressed their support for consolidating the IPRF and IGPRR initiatives to better address the issues Complex and challenges faced by regulatory authorities and organizations.
The consolidation of these two regulatory collaborations should allow for a shared vision for information exchange and regulatory cooperation, maximize synergies and avoid duplication efforts, create a regulatory center for pharmaceutical products that covers all Allowing for closer links with initiatives to simplify the many forms of international regulatory collaboration and improve governance for management committees and technical working groups.
The Consolidated Management Committee intends to hold its first face-to-face meeting in June 2018.
"Given the imminent consolidation of the IPRF with IGDRP, a revised joint strategic vision will be developed for the consolidated entity in the near future," said IPRF.
In addition, the International Council for Harmonization (ICH) Assembly approved a proposal by the IPRF Management Committee that the ICH Secretariat provide support services to the IPRF as of 1 January 2018.
"The Secretariat's support services will cover the needs of the future consolidated entity IPRF and IGDRP," the group added.
The next meeting of the IPRF Management Committee will be held on 12 and 13 November 2017 in Geneva, Switzerland.
